Increased leptin/adiponectin ratio relates to low-normal thyroid function in metabolic syndrome

Lynnda J. N. van Tienhoven‐Wind, Robin P. F. Dullaart

Lipids in Health and Disease · 2017 · 10 citations · 26 references

DOIFull text

Open access

Concepts

Abstract

Low-normal thyroid function within the euthyroid range may contribute to increased atherosclerosis susceptibility. The leptin/adiponectin (L/A) ratio is associated with cardiovascular disease and reflects adipose tissue dysfunction. Relationships of the L/A ratio with low-normal thyroid function are unknown. Relationships of thyroid stimulating hormone (TSH) and free thyroxine (free T 4 ) with leptin, adiponectin and the L/A ratio in euthyroid subjects were documented in 67 fasting subjects with metabolic syndrome (Mets) and 86 euthyroid subjects without MetS (TSH and free T 4 levels within the institutional reference range). Neither plasma leptin nor adiponectin was significantly correlated with TSH or free T 4 in subjects with and without MetS. In the whole group, high sensitivity C-reactive protein (hs-CRP) was positively correlated with the L/A ratio ( r = 0.485, P < 0.001). Notably, the L/A ratio was positively correlated with TSH in subjects with MetS ( r = 0.252, P = 0.040) but not in subjects without MetS ( r = −0.068, P = 0.54; interaction term, P = 0.027). In MetS subjects, the L/A ratio remained positively related with TSH after adjustment for age, sex, diabetes status, hs-CRP and the use of antihypertensive and glucose lowering medication (β = 0.283, P = 0.018), as well as after adjustment for individual MetS components (β = 0.294, P = 0.020). In the context of MetS, a higher TSH within the euthyroid range confers an increased L/A ratio, a proposed marker of atherosclerosis susceptibility and adipocyte dysfunction.

References

26